[go: up one dir, main page]

GB201511121D0 - Cancer therapy - Google Patents

Cancer therapy

Info

Publication number
GB201511121D0
GB201511121D0 GBGB1511121.4A GB201511121A GB201511121D0 GB 201511121 D0 GB201511121 D0 GB 201511121D0 GB 201511121 A GB201511121 A GB 201511121A GB 201511121 D0 GB201511121 D0 GB 201511121D0
Authority
GB
United Kingdom
Prior art keywords
cancer therapy
cancer
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1511121.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immodulon Therapeutics Ltd
Original Assignee
Immodulon Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immodulon Therapeutics Ltd filed Critical Immodulon Therapeutics Ltd
Priority to GBGB1511121.4A priority Critical patent/GB201511121D0/en
Publication of GB201511121D0 publication Critical patent/GB201511121D0/en
Priority to KR1020187002124A priority patent/KR20180015269A/en
Priority to US15/738,674 priority patent/US11207405B2/en
Priority to PT167340132T priority patent/PT3319635T/en
Priority to EP16734013.2A priority patent/EP3319635B1/en
Priority to AU2016281765A priority patent/AU2016281765B2/en
Priority to CN201680041523.8A priority patent/CN107847598B/en
Priority to ES16734013T priority patent/ES2879248T3/en
Priority to JP2018518795A priority patent/JP6892443B2/en
Priority to CA2990107A priority patent/CA2990107C/en
Priority to MX2017016931A priority patent/MX389834B/en
Priority to PL16734013T priority patent/PL3319635T3/en
Priority to EP21167914.7A priority patent/EP3868406A1/en
Priority to BR112017028163-5A priority patent/BR112017028163B1/en
Priority to RU2018102547A priority patent/RU2733033C2/en
Priority to CN202210021724.9A priority patent/CN114344462B/en
Priority to PCT/GB2016/051893 priority patent/WO2016207646A1/en
Priority to IL256467A priority patent/IL256467B/en
Priority to JP2021089422A priority patent/JP7393384B2/en
Priority to US17/645,391 priority patent/US20220111046A1/en
Priority to JP2023112304A priority patent/JP2023118968A/en
Ceased legal-status Critical Current

Links

GBGB1511121.4A 2015-06-24 2015-06-24 Cancer therapy Ceased GB201511121D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB1511121.4A GB201511121D0 (en) 2015-06-24 2015-06-24 Cancer therapy
PCT/GB2016/051893 WO2016207646A1 (en) 2015-06-24 2016-06-24 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
MX2017016931A MX389834B (en) 2015-06-24 2016-06-24 CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBATERIUM FOR USE IN CANCER THERAPY.
EP21167914.7A EP3868406A1 (en) 2015-06-24 2016-06-24 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
PT167340132T PT3319635T (en) 2015-06-24 2016-06-24 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
EP16734013.2A EP3319635B1 (en) 2015-06-24 2016-06-24 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
AU2016281765A AU2016281765B2 (en) 2015-06-24 2016-06-24 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
CN201680041523.8A CN107847598B (en) 2015-06-24 2016-06-24 Checkpoint inhibitors and whole cell mycobacteria for cancer therapy
ES16734013T ES2879248T3 (en) 2015-06-24 2016-06-24 Whole cell mycobacterium and checkpoint inhibitor for use in cancer therapy
JP2018518795A JP6892443B2 (en) 2015-06-24 2016-06-24 Checkpoint inhibitors and whole-cell mycobacteria for use in cancer treatment
CA2990107A CA2990107C (en) 2015-06-24 2016-06-24 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
KR1020187002124A KR20180015269A (en) 2015-06-24 2016-06-24 Checkpoint inhibitor for use in cancer treatment and whole cell of Mycobacterium
PL16734013T PL3319635T3 (en) 2015-06-24 2016-06-24 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
US15/738,674 US11207405B2 (en) 2015-06-24 2016-06-24 Checkpoint inhibitor and a whole cell Mycobacterium for use in cancer therapy
BR112017028163-5A BR112017028163B1 (en) 2015-06-24 2016-06-24 USE OF MYCOBACTERIUM OBUENSE AS AN IMMUNOMODULATOR IN CANCER THERAPY
RU2018102547A RU2733033C2 (en) 2015-06-24 2016-06-24 Control point inhibitor and whole mycobacterial cells for use in cancer therapy
CN202210021724.9A CN114344462B (en) 2015-06-24 2016-06-24 Checkpoint inhibitors and whole cell mycobacteria for cancer treatment
IL256467A IL256467B (en) 2015-06-24 2017-12-21 A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
JP2021089422A JP7393384B2 (en) 2015-06-24 2021-05-27 Checkpoint inhibitors and whole cell mycobacteria for use in cancer therapy
US17/645,391 US20220111046A1 (en) 2015-06-24 2021-12-21 Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
JP2023112304A JP2023118968A (en) 2015-06-24 2023-07-07 Checkpoint inhibitor and whole cell mycobacterium for use in cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1511121.4A GB201511121D0 (en) 2015-06-24 2015-06-24 Cancer therapy

Publications (1)

Publication Number Publication Date
GB201511121D0 true GB201511121D0 (en) 2015-08-05

Family

ID=53784452

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1511121.4A Ceased GB201511121D0 (en) 2015-06-24 2015-06-24 Cancer therapy

Country Status (1)

Country Link
GB (1) GB201511121D0 (en)

Similar Documents

Publication Publication Date Title
IL259017A (en) Targeted cancer therapy
IL254705B (en) Combination therapy for cancer
ZA201702382B (en) Combination therapy for cancer
PT3423087T (en) Combination therapy against cancer
SMT201800303T1 (en) Cancer treatments
GB201516442D0 (en) Combination therapy
IL249898A0 (en) Combination therapy for cancer
IL257976A (en) Combination therapy
IL260076A (en) Combination therapy
IL246761A0 (en) Combination therapy for cancer
GB201519734D0 (en) Cancer therapy
GB201522433D0 (en) Cancer treatment
GB201704909D0 (en) Cancer therapy
IL259097A (en) Combination therapy for cancer
GB201711855D0 (en) Cancer therapy
GB201511609D0 (en) Cancer therapy
GB201511121D0 (en) Cancer therapy
GB201511120D0 (en) Cancer therapy
GB201711250D0 (en) Cancer therapy
GB201710198D0 (en) Cancer therapy
HRP20210383T8 (en) Combination therapy for cancer
GB201601248D0 (en) Cancer therapy
GB201706046D0 (en) Cancer therapy
GB201700772D0 (en) Cancer therapy
GB201411884D0 (en) Cancer therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)